Kopelman, 2007, Health risks associated with overweight and obesity, Obes Rev, 8, 13, 10.1111/j.1467-789X.2007.00311.x
Boden, 2002, Interaction between free fatty acids and glucose metabolism, Curr Opin Clin Nutr Metab Care, 5, 545, 10.1097/00075197-200209000-00014
Cnop, 2008, Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes, Biochem Trans, 36, 348, 10.1042/BST0360348
Maloney, 2009, Activation of NF-κB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation, ArteriosclerThrombVasc Biol, 29, 1370, 10.1161/ATVBAHA.109.188813
Snodgrass, 2013, Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids, J Immunol, 191, 4337, 10.4049/jimmunol.1300298
Chavez, 2003, Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes, Arch Biochem, 419, 101, 10.1016/j.abb.2003.08.020
Coll, 2008, Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells, J Biol Chem, 283, 11107, 10.1074/jbc.M708700200
Sinha, 2004, Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B, J Biol Chem, 279, 41294, 10.1074/jbc.M406514200
Yuzefovych, 2010, Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress, Am J Physiol Endocrinol Metab, 299, E1096, 10.1152/ajpendo.00238.2010
Peng, 2011, Oleate blocks palmitate-induced abnormal lipid distribution, endoplasmic reticulum expansion and stress, and insulin resistance in skeletal muscle, Endocrinology, 152, 2206, 10.1210/en.2010-1369
Turpin, 2006, Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance, Am J Physiol Endocrinol Metab, 291, E1341, 10.1152/ajpendo.00095.2006
Bunn, 2010, Palmitate and insulin synergistically induce IL-6 expression in human monocytes, Cardiovasc Diabetol, 9, 73, 10.1186/1475-2840-9-73
Riserus, 2009, Dietary fats and prevention of type 2 diabetes, Prog Lipid Res, 48, 44, 10.1016/j.plipres.2008.10.002
Campbell, 2004, A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria, J Biol Chem, 279, 36235, 10.1074/jbc.M400566200
Stewart, 2010, CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer, Nat Immunol, 11, 155, 10.1038/ni.1836
Kusminski, 2009, Diabetes and apoptosis: lipotoxicity, Apoptosis, 14, 1484, 10.1007/s10495-009-0352-8
Nelson, 1990, Periodontal disease and NIDDM in Pima Indians, Diabetes Care, 13, 836, 10.2337/diacare.13.8.836
Saito, 1998, Obesity and periodontitis, N Engl J Med, 339, 482, 10.1056/NEJM199808133390717
Tervonen, 2000, Alveolar bone loss in type 1 diabetic subjects, J Clin Periodontol, 27, 567, 10.1034/j.1600-051x.2000.027008567.x
Kang, 2010, Comorbidities in patients with primary Sjögren's syndrome: a registry-based case-control study, J Rheumatol, 37, 1188, 10.3899/jrheum.090942
Ramos-Casals, 2007, High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression, J Rheumatol, 34, 754
Sekiguchi, 2008, Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome, J Immunol, 180, 1921, 10.4049/jimmunol.180.3.1921
Chan, 1991, Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen, J Clin Invest, 87, 68, 10.1172/JCI115003
Haneji, 1997, Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome, Science, 276, 604, 10.1126/science.276.5312.604
Shikama, 2013, Effects of free fatty acids on human salivary gland epithelial cells, J Dent Res, 92, 540, 10.1177/0022034513487378
Leigh, 2014, Expression of resolvin D1 biosynthetic pathways in salivary epithelium, J Dent Res, 93, 300, 10.1177/0022034513519108
Azuma, 2000, Arthritis Rheum, 43, 1756, 10.1002/1529-0131(200008)43:8<1756::AID-ANR12>3.0.CO;2-H
Nelson, 2014, ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands, Am J Physiol Cell Physiol, 306, C178, 10.1152/ajpcell.00284.2013
Odusanwo, 2012, Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation, Am J Physiol Cell Physiol, 302, C1331, 10.1152/ajpcell.00207.2011
Darveau, 2010, Periodontitis: a polymicrobial disruption of host homeostasis, Nat Rev Microbiol, 8, 481, 10.1038/nrmicro2337
Almasri, 2007, Nicotine and lipopolysaccharide affect cytokine expression from gingival fibroblasts, J Periodontol, 78, 533, 10.1902/jop.2007.060296
Kusumoto, 2004, Human gingival epithelial cells produce chemotactic factors interleukin-8 and monocyte chemoattractant protein-1 after stimulation with Porphyromonasgingivalis via toll-like receptor 2, J Periodontol, 75, 370, 10.1902/jop.2004.75.3.370
Shikama, 2015, Possible involvement of palmitate in pathogenesis of periodontitis, J Cell Physiol, 230, 2981, 10.1002/jcp.25029
Muluke, 2016, Diet-induced obesity and its differential impact on periodontal bone loss, J Dent Res, 95, 223, 10.1177/0022034515609882
Lu, 2017, CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate, Oral Dis, 23, 210, 10.1111/odi.12596
Ao, 2014, Infection with Porphyromonasgingivalis exacerbates endothelial injury in obese mice, PLoS One, 9, e110519, 10.1371/journal.pone.0110519
Furusho, 2013, Dental infection of Porphyromonasgingivalis exacerbates high fat diet-induced steatohepatitis in mice, J Gastroenterol, 48, 1259, 10.1007/s00535-012-0738-1
Naqvi, 2014, Docosahexaenoic acid and periodontitis in adults: a randomized controlled trial, J Dent Res, 93, 767, 10.1177/0022034514541125
Khaled, 2013, Effects of resolvin D1 on cell survival and cytokine expression of human gingival fibroblasts, J Periodontol, 84, 1838, 10.1902/jop.2013.120388
Hasturk, 2006, RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis, FASEB J, 20, 401, 10.1096/fj.05-4724fje
Elabdeen, 2013, Ratio of pro-resolving and pro-inflammatory lipid mediator precursors as potential markers for aggressive periodontitis, PLoS One, 8, e70838, 10.1371/journal.pone.0070838
Springer, 1994, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm, Cell, 76, 301, 10.1016/0092-8674(94)90337-9
Woollard, 2010, Monocytes in atherosclerosis: subsets and functions, Nat Rev Cardiol, 7, 77, 10.1038/nrcardio.2009.228
Haraldsen, 1996, Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells, J Immunol, 156, 2558, 10.4049/jimmunol.156.7.2558
Szekanecz, 1994, Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms, Clin Exp Immunol, 98, 337, 10.1111/j.1365-2249.1994.tb06147.x
Maedler, 2002, Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets, J Clin Invest, 110, 851, 10.1172/JCI200215318
von der Thusen, 2003, Interleukins in atherosclerosis: molecular pathways and therapeutic potential, Pharmacol Rev, 55, 133, 10.1124/pr.55.1.5
Kirii, 2003, Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice, ArteriosclerThromb Vasc Biol, 23, 656, 10.1161/01.ATV.0000064374.15232.C3
Takahashi, 1996, Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells, Cardiovasc Res, 32, 422, 10.1016/0008-6363(96)00085-5
Arend, 1991, IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently, J Immunol, 147, 1530, 10.4049/jimmunol.147.5.1530
Poutsiaka, 1991, Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated, Blood, 78, 1275, 10.1182/blood.V78.5.1275.1275
Arend, 2002, The balance between IL-1 and IL-1Ra in disease, Cytokine Growth Factor Rev, 13, 323, 10.1016/S1359-6101(02)00020-5
Johnston, 2013, Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation, ArteriosclerThromb Vasc Biol, 33, 294, 10.1161/ATVBAHA.112.300432
Shikama, 2015, Palmitate-stimulated monocytes induce adhesion molecule expression in endothelial cells via IL-1 signaling pathway, J Cell Physiol, 230, 732, 10.1002/jcp.24797
Isoda, 2005, Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice, J Biol Chem, 280, 7002, 10.1074/jbc.M412220200
Ehses, 2009, IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat, Proc Natl Acad Sci USA, 106, 13998, 10.1073/pnas.0810087106
Van Tassell, 2013, Targeting interleukin-1 in heart disease, Circulation, 128, 1910, 10.1161/CIRCULATIONAHA.113.003199